Skip to main content

Table 1 Course of laboratory tests over time in patient 1

From: Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

Days from admission at Authors’ center

0

+ 14

+ 45a

+ 50

+ 80

White blood cells (× 103/mm3)

17.9

10.4

44.5

11.4

8.9

Neutrophil count (×103/mm3)

15.0

8.9

41.7

6.4

5.0

Hemoglobin (g/dL)

10.3

10.6

9.3

9.8

12.5

Platelet count (×103/mm3)

482

320

418

459

315

Erythrocyte sedimentation rate (mm/h)

59

37

57

61

18

C-reactive protein (mg/dL)

8.2

4.9

11.5

1.5

<  0.46

Aspartate aminotransferase (U/L)

229

68

170

127

12

Lactate dehydrogenase (U/L)

1752

951

956

862

853

Triglycerides (mg/dL)

112

158

133

226

107

Fibrinogen (mg/dL)

341

442

415

251

287

Ferritin (ng/mL)

13,200

8550

18,000

4099

581

  1. aStart of canakinumab administration